Subsequent analysis of selected proteins in sEVs of stage I, stage III, stage IV melanoma patients and healthy controls revealed a potential diagnostic “signature”, which included the melanoma-specific protein TYRP2, VLA-4, HSP70, an isoform of HSP90 and oncoprotein MET [90]. Here, DCT is linked to melanoma.